Jecure Therapeutics Inc.

About Jecure Therapeutics Inc.

Jecure Therapeutics is focused on the discovery of novel therapeutics for the treatment of fatty liver disease, NASH, and fibrosis. Our scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. Jecure Therapeutics combines cutting-edge academic biology with deeply experienced pharma/biotech scientists who are dedicated to discovering novel and impactful therapeutics for the treatment of liver disease.

YEAR FOUNDED:

2017

LEADERSHIP:

Founder: Ariel Feldstein

President and CEO: Jeffrey A. Stafford, PhD

CSO: James M. Veal, PhD

CAREER:

Please click here for Jecure Therapeutics' job opportunities.